AstraZeneca Pharmaceuticals (Ireland) DAC (AstraZeneca)

Lobbying Organisation AstraZeneca Pharmaceuticals (Ireland) DAC

Date published 20 Jan, 2023

Relevant Matter Public policy or programme

Public Policy Area Health

Period 1 Sep, 2022 to 31 Dec, 2022

Specific Details COPD Policy in Ireland

Intended results Attended COPD parliamentary briefing on COPD policies in Ireland, including diagnosis and management

Name of person primarily responsible for lobbying on this activity Colin O'Donnell

Did any Designated Public Official(DPO) or former Designated Public Official(DPO) carry out lobbying activities on your behalf in relation to this return? You must include yourself, and answer Yes, if you are a current DPO or a DPO at any time in the past. (What is a Designated Public Official?) No

Did you manage or direct a grassroots campaign? No

Was this lobbying done on behalf of a client? No

Lobbying activity

The following activities occurred for this specific Subject Matter Area.

Meeting (1)

Attended parliamentary briefing with subsequent meeting with Denis Naughten on COPD policy in Ireland

Designated public officials lobbied

The following DPOs were lobbied during this return period on this specific Subject Matter Area. These DPOs were involved in at least one of the Lobbying Activities listed above, but not necessarily all of them. As returns are specific to a Subject Matter Area the above Lobbying Activities may be associated with multiple returns.

Denis Naughten TD (Dáil Éireann, the Oireachtas)